Literature DB >> 33070036

Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.

Yang Gu1, Xiaodan Chu2, John A Morgan1, David F Lewis1, Yuping Wang3.   

Abstract

INTRODUCTION: N6-methyladenosine (m6A) has been recognized as one of the most abundant and functionally relevant modifications of RNAs and plays critical roles in biological and pathological processes. Placental trophoblast dysfunction significantly contributes to the pathogenesis of preeclampsia. The present study aimed to determine if altered m6A expression occurs in placental trophoblasts in preeclampsia. Expression of m6A methyltransferase (methyltransferase like 3 (METTL3)), m6A demethylases (fat mass and obesity-associated protein (FTO) and AlkB homolog 5 (ALKBH5)), and m6A reader protein, heterogeneous nuclear ribonucleoprotein C1/C2 (hnRNPC1/C2), were also examined.
METHODS: A total of 43 placentas (20 normal term, 5 normotensive preterm, and 18 preeclamptic) were used in the study. Expression of m6A, METTL3, FTO, ALKBH5, and hnRNPC1/C2 were examined by immunostaining in villous tissue sections and/or by Western blot of total cellular protein in trophoblasts isolated from normotensive and preeclamptic placentas. Total RNA extracted from trophoblasts was used to measure m6A RNA methylation. Effects of METTL3 on m6A RNA methylation and hnRNPC1/C2 expression were assessed by transfection of METTL3 siRNA in trophoblasts from preeclamptic placentas.
RESULTS: Expression of m6A and m6A RNA methylation were significantly increased in trophoblasts from preeclamptic vs. normotensive placentas, p < 0.05. Expression of METTL3 and hnRNPC1/C2, but not FTO and ALKBH5, was significantly upregulated in trophoblasts from preeclamptic vs. normotensive placentas, p < 0.01. Transfection of METTL3 siRNA significantly reduced the level of m6A RNA methylation and hnRNPC1/C2 expression in trophoblasts from preeclamptic placentas, p < 0.05.
CONCLUSION: The finding of increased METTL3 expression and m6A RNA methylation associated with increased hnRNPC1/C2 expression provides a new posttranscriptional mechanism that aberrant m6A modification may contribute to trophoblast dysfunction in preeclampsia.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FTO; METTL3; Placental trophoblast; Preeclampsia; hnRNPC1/C2; m6A

Mesh:

Substances:

Year:  2020        PMID: 33070036     DOI: 10.1016/j.placenta.2020.10.016

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

Authors:  Shengshu Li; Xiaoxin Lu; Dongyang Zheng; Weizong Chen; Yuzhu Li; Fang Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-30       Impact factor: 4.322

Review 2.  N6-Methyladenosine Modifications in the Female Reproductive System: Roles in Gonad Development and Diseases.

Authors:  Hongbei Mu; Huiying Li; Yu Liu; Xiaofei Wang; Qiaojuan Mei; Wenpei Xiang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 3.  The Placenta as a Target of Epigenetic Alterations in Women with Gestational Diabetes Mellitus and Potential Implications for the Offspring.

Authors:  Dennise Lizárraga; Alejandra García-Gasca
Journal:  Epigenomes       Date:  2021-05-10

4.  circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion.

Authors:  Yonggang Zhang; Hongling Yang; Yan Long; Yipeng Zhang; Ronggui Chen; Junzhu Shi; Jiying Chen
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

5.  Gene model-related m6A expression levels predict the risk of preeclampsia.

Authors:  Yiwei Li; Can Chen; Mengyuan Diao; Yanli Wei; Ying Zhu; Wei Hu
Journal:  BMC Med Genomics       Date:  2022-05-05       Impact factor: 3.622

Review 6.  The regulation and potential roles of m6A modifications in early embryonic development and immune tolerance at the maternal-fetal interface.

Authors:  Hong Liu; Jie Zheng; Aihua Liao
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.